Signify Health, Inc. (NYSE:SGFY – Get Rating) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 8,350,000 shares, a growth of 36.0% from the May 31st total of 6,140,000 shares. Based on an average daily volume of 1,540,000 shares, the short-interest ratio is currently 5.4 days. Currently, 11.9% of the company’s shares are sold short.
Several equities analysts have recently weighed in on SGFY shares. Piper Sandler raised their price objective on Signify Health from $27.00 to $32.00 and gave the company an “overweight” rating in a report on Monday, June 6th. Robert W. Baird upgraded Signify Health from a “neutral” rating to an “outperform” rating and decreased their price objective for the company from $19.00 to $16.00 in a report on Monday, May 16th. The Goldman Sachs Group raised their price objective on Signify Health from $20.00 to $22.00 and gave the company a “buy” rating in a report on Monday, March 21st. UBS Group upgraded Signify Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $20.00 to $21.00 in a report on Wednesday, March 9th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Signify Health from $29.00 to $26.00 in a report on Friday, May 6th. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $26.33.
Shares of SGFY opened at $14.86 on Friday. The firm has a market capitalization of $3.47 billion, a PE ratio of 78.21, a PEG ratio of 2.62 and a beta of 1.55. The company’s 50-day moving average is $13.31 and its 200-day moving average is $14.21. Signify Health has a fifty-two week low of $10.70 and a fifty-two week high of $30.89. The company has a debt-to-equity ratio of 0.22, a current ratio of 4.82 and a quick ratio of 4.82.
Signify Health (NYSE:SGFY – Get Rating) last issued its quarterly earnings data on Wednesday, May 4th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.08. The company had revenue of $216.50 million for the quarter, compared to analyst estimates of $213.21 million. Signify Health had a net margin of 3.95% and a return on equity of 3.22%. The company’s revenue was up 20.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.20 earnings per share. Analysts predict that Signify Health will post 0.13 earnings per share for the current fiscal year.
In other news, CEO Bradford Kyle Armbrester acquired 8,320 shares of Signify Health stock in a transaction dated Monday, May 9th. The stock was bought at an average cost of $11.77 per share, with a total value of $97,926.40. Following the completion of the transaction, the chief executive officer now directly owns 92,693 shares of the company’s stock, valued at $1,090,996.61. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Steve Senneff acquired 10,000 shares of Signify Health stock in a transaction dated Friday, May 6th. The shares were purchased at an average cost of $12.55 per share, with a total value of $125,500.00. Following the completion of the transaction, the insider now directly owns 215,087 shares of the company’s stock, valued at $2,699,341.85. The disclosure for this purchase can be found here. Insiders acquired 20,820 shares of company stock valued at $252,801 in the last ninety days. Insiders own 8.02% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the company. New York State Common Retirement Fund lifted its holdings in shares of Signify Health by 180.4% during the fourth quarter. New York State Common Retirement Fund now owns 71,234 shares of the company’s stock worth $1,013,000 after buying an additional 45,834 shares in the last quarter. Morgan Stanley lifted its holdings in shares of Signify Health by 19.4% during the third quarter. Morgan Stanley now owns 1,021,240 shares of the company’s stock worth $18,249,000 after buying an additional 166,217 shares in the last quarter. Balyasny Asset Management LLC acquired a new stake in shares of Signify Health during the third quarter worth $552,000. Voya Investment Management LLC acquired a new stake in shares of Signify Health during the third quarter worth $179,000. Finally, Nikko Asset Management Americas Inc. lifted its holdings in shares of Signify Health by 12.2% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 5,525,816 shares of the company’s stock worth $77,969,000 after buying an additional 601,657 shares in the last quarter.
Signify Health Company Profile (Get Rating)
Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient’s home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.
Read More
Receive News & Ratings for Signify Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Signify Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
